Literature DB >> 145245

The binding of aurovertin to isolated beta subunit of F1 (mitochondrial ATPase). Stoicheiometry of beta subunit in F1.

G J Verschoor, P R van der Sluis, E C Slater.   

Abstract

1. Beef-heart mitochondrial ATPase (F1) is inactivated and dissociated by incubation with 0.85 M LiCl. ATP partly protects against inactivation. Three dissociation products could be identified after chromatography on diethylaminoethylcellulose: the delta subunit which is not adsorbed, the beta subunit which may be eluted from the column, and the alpha and gamma subunits which remain bound to the column. 2. Aurovertin binds to dissociated F1 with a fluorescence enhancement equal to about 30% that found with F1. Unlike intact F1 which shows two kinetically separated phases of fluorescence enhancement, only a fast phase is found with dissociated enzyme. 3. Fluorescence measurements at varying aurovertin and protein concentrations indicate that aurovertin binds to dissociated F1 in a simple 3-component reaction with dissociation constant 0.4 muM. There are two indistinguishable binding sites, calculated on the basis of the initial F1 concentration before dissociation. 4. The beta subunit was isolated from dissociated F1 by DEAE-cellulose chromatography. It has no ATPase activity but reacts with aurovertin with a fluorescence enhancement similar to that of dissociated F1. 5. The isolated beta subunit contains one aurovertin binding site with a dissociation constant of 0.56 muM. 6. It is concluded that F1 contains two beta subunits.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 145245     DOI: 10.1016/0005-2728(77)90141-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B.

Authors:  M J van Raaij; J P Abrahams; A G Leslie; J E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  The stoichiometry of binding of the aurovertins to mitochondrial ATPases: revision of the molar absorption coefficient.

Authors:  P E Linnett; L J Mulheirn; R B Beechey
Journal:  J Bioenerg Biomembr       Date:  1983-04       Impact factor: 2.945

Review 3.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 4.  Structure and function of H+-ATPase.

Authors:  Y Kagawa; N Sone; H Hirata; M Yoshida
Journal:  J Bioenerg Biomembr       Date:  1979-08       Impact factor: 2.945

Review 5.  Chemical modification of active sites in relation to the catalytic mechanism of F1.

Authors:  J H Wang
Journal:  J Bioenerg Biomembr       Date:  1988-08       Impact factor: 2.945

6.  Structure of the mitochondrial F1 ATPase at 9-A resolution.

Authors:  L M Amzel; M McKinney; P Narayanan; P L Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Isolation of alpha-subunits of factor F1 from submitochondrial particles and the reconstitution of active ATPase from isolated alpha-subunits and beta-subunits bound to the mitochondrial membrane.

Authors:  I A Kozlov; Y M Milgrom; I S Tsybovski
Journal:  Biochem J       Date:  1980-11-15       Impact factor: 3.857

Review 8.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

9.  Studies on the mechanism of oxidative phosphorylation: effects of specific F0 modifiers on ligand-induced conformation changes of F1.

Authors:  A Matsuno-Yagi; T Yagi; Y Hatefi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 10.  Recent developments on structural and functional aspects of the F1 sector of H+-linked ATPases.

Authors:  P V Vignais; M Satre
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.